Specific Hormone Testing for Patients with Obesity Seeking Weight Loss
For patients with obesity seeking weight loss, a basic laboratory evaluation should include comprehensive metabolic panel, fasting lipid profile, thyroid function tests, and screening for abnormal blood glucose, with additional targeted hormone testing based on clinical presentation. 1
Core Laboratory Tests for All Patients with Obesity
Basic Laboratory Panel:
- Comprehensive metabolic panel (liver and kidney function)
- Fasting lipid profile (total cholesterol, HDL, LDL, triglycerides)
- Thyroid function tests (TSH, free T4)
- Fasting blood glucose and HbA1c 1
Anthropometric Measurements:
- BMI calculation
- Waist circumference measurement (≥102 cm for men and ≥88 cm for women indicates increased cardiometabolic risk) 1
Hormone Testing Based on Clinical Presentation
For All Patients:
- Thyroid Function Tests:
For Men with Symptoms of Hypogonadism:
- Sex Hormone Panel:
- Morning total testosterone (essential)
- Sex hormone-binding globulin (SHBG)
- Free testosterone calculation or direct measurement
- Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) 4
For Women with Irregular Menstruation or Hirsutism:
- PCOS Evaluation:
For Suspected Cushing's Syndrome:
- Cortisol Testing:
Additional Testing Based on Specific Findings
If Acanthosis Nigricans Present:
- Fasting insulin levels
- HOMA-IR (homeostasis model assessment of insulin resistance) 1
If Sleep Disturbances Present:
- Screen for obstructive sleep apnea using validated tools (Epworth Sleepiness Scale, STOPBANG questionnaire) 1
If Osteoporosis Suspected:
- Vitamin D levels
- Parathyroid hormone levels 6
Interpretation and Clinical Significance
Thyroid Function: Hypothyroidism is common in obesity and should be treated if present, though weight loss effects from treatment are modest 2, 3
Sex Hormones:
- In men: Low total testosterone with normal/low SHBG suggests obesity-related hypogonadism
- In women: Elevated free androgen index (>0.3) suggests PCOS 4
Cortisol: Elevated cortisol with failure to suppress after dexamethasone suggests Cushing's syndrome, though this is rare in obesity (<0.6% prevalence) 5
Clinical Pitfalls to Avoid
Over-testing: Most endocrine testing is not recommended in the absence of specific clinical features suggesting an endocrine disorder 3
Misinterpreting Results: Many hormonal abnormalities in obesity are consequences rather than causes of obesity and normalize with weight loss 6, 5
Overlooking Secondary Causes: While rare, endocrine disorders like Cushing's syndrome, hypothyroidism, and insulinoma can cause or exacerbate obesity and should be ruled out when clinically suspected 7
Ignoring SHBG: Low SHBG is common in obesity and affects interpretation of total testosterone levels; free testosterone or bioavailable testosterone should be measured in obese patients 4
Missing PCOS: In women with obesity, PCOS is common and may benefit from specific treatments including anti-obesity medications like exenatide or liraglutide 1, 4
Remember that successful weight loss often normalizes many hormone abnormalities found in obesity, including TSH elevation and testosterone levels, suggesting these are often consequences rather than causes of obesity 5.